Ratio Therapeutics is innovating in the field of cancer treatment with its advanced platforms, TRILLIUM™ and MACROPA™, which enhance radioligand pharmacokinetics and streamline the production of actinium-225. Focused on targeted radioligand therapy, we are committed to developing novel therapeutic candidates that aim to improve cancer patients' lives without compromising their quality of life.
No jobs found. Subscribe below to get notified when we find something for you.
Searching